Granulomatosis with polyangiitis with lacrimal gland enlargement and pancreatic swelling: A case report and a literature review

Mod Rheumatol Case Rep. 2025 Jan 16;9(1):155-162. doi: 10.1093/mrcr/rxae066.

Abstract

A 62-year-old man had bilateral eyelid swelling for 4 months. Two months before admission, he developed fatigue and lost 5 kg of body weight. Further examination revealed elevated serum C-reactive protein, normal angiotensin-converting enzyme, elevated proteinase-3 antineutrophil cytoplasmic antibody (PR3-ANCA), and normal immunoglobulin (Ig)G4 concentration. Chest X-ray and computed tomography showed no enlarged hilar lymph nodes, but positron emission tomography-computed tomography showed fluorodeoxyglucose accumulation in both lacrimal glands, in lung nodules, and in the pancreas. Tissue biopsies of the lacrimal glands and pulmonary nodules showed granuloma with giant cells, but no IgG4-positive cells or fibrosis. Pancreatic tissue showed no findings of autoimmune pancreatitis. In the 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis, the total score was 10 points. Final comprehensive diagnosis was granulomatosis with polyangiitis, based on the negative results of differential diseases, such as IgG4-related diseases and sarcoidosis. Prednisolone 60 mg/day was started on Day 8, and rituximab 500 mg/body/week on Day 12. After beginning treatment, general malaise and lacrimal gland enlargement were resolved, PR3-ANCA and C-reactive protein became negative, and the nodular shadow in the lungs disappeared. This is the first report of granulomatosis with polyangiitis presenting both lacrimal gland and pancreatic lesions.

Keywords: Granulomatosis with polyangiitis; lacrimal gland enlargement; pancreatic enlargement.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Granulomatosis with Polyangiitis* / complications
  • Granulomatosis with Polyangiitis* / diagnosis
  • Humans
  • Lacrimal Apparatus / pathology
  • Male
  • Middle Aged
  • Pancreas / pathology
  • Prednisolone / administration & dosage
  • Prednisolone / therapeutic use
  • Rituximab / administration & dosage
  • Rituximab / therapeutic use
  • Treatment Outcome

Substances

  • Prednisolone
  • Rituximab